Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Condition(s):Hypertension; Angina Pectoris; Hypercholesterolemia; Familial HypercholesterolemiaLast Updated:January 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Hypertension; Angina Pectoris; Hypercholesterolemia; Familial HypercholesterolemiaLast Updated:January 28, 2021Completed
Condition(s):Hypertension; Hypercholesterolemia; Angina PectorisLast Updated:January 28, 2021Completed
Condition(s):Metabolic SyndromeLast Updated:June 13, 2018Completed
Condition(s):Hypertension With HyperlipidemiaLast Updated:March 12, 2018Completed
Condition(s):Hypertension; DyslipidemiaLast Updated:January 27, 2021Completed
Condition(s):Hypertension and Cardiovascular Risk FactorsLast Updated:January 28, 2021Terminated
Condition(s):Hypertension; HypercholesterolemiaLast Updated:January 28, 2021Completed
Condition(s):Hypertension; DyslipidemiaLast Updated:January 27, 2021Completed
Condition(s):Healthy VolunteersLast Updated:February 10, 2020Completed
Condition(s):Hypertension; DyslipidemiasLast Updated:March 1, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.